EX-16.1 6 d785680dex161.htm EX-16.1 EX-16.1

Exhibit 16.1



November 1, 2019

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549


We have read the statements made by Orchard Therapeutics plc pursuant to Item 5 of Form F-3 (copy attached), which we understand will be filed with the Securities and Exchange Commission as part of the Registration Statement on Form F-3 dated November 1, 2019. We agree with the statements concerning our Firm contained therein.


Very truly yours,
/s/ PricewaterhouseCoopers LLP
United Kingdom

PricewaterhouseCoopers LLP, 3 Forbury Place, 23 Forbury Road, Reading, Berkshire, RG1 3JH

T: +44 (0) 118 597 111, F: +44 (0) 1189 383 020, www.pwc.co.uk

PricewaterhouseCoopers LLP is a limited liability partnership registered in England with registered number OC303525. The registered office of PricewaterhouseCoopers LLP is 1 Embankment Place, London WC2N 6RH. PricewaterhouseCoopers LLP is authorised and regulated by the Financial Conduct Authority for designated investment business.